Protocols


Preparation of minihepcidins for injection

MW of PR73 = 1,783 Da (but peptide is assumed to be 80% of powder weight) 1 nmole = 1733 ng = 1.7 μg pure peptide or 2.2 μg 80% peptide. We have used doses between 10 and 100 nmoles (100 nmoles is a very high dose that causes profound hypoferremia).

50 nmol PR73 dose per mouse = ~0.11 mg PR73 and 1.5 mg solvent (SL220).

Use 100 μl volume for subcutaneous or IP injection.

To make enough for (for example) twenty 50 nmol doses:

  • Take 2.2 mg PR73 powder + 350 μl 80% ethanol (2.2 mg instead of 1.73 mg because the peptide is 80% of powder weight)
  • Take 30 mg SL220 + 350 μl 80% ethanol, warm up to 37 C to dissolve (a few seconds)
  • Mix PR73 and SL220, and warm up again if it is difficult to dissolve
  • Split liquid between two tubes, and dry in Speedvac until gel is formed
  • Add 1 ml injectable quality water per tube for 0.5 nmol/μl concentration, vortex until gel is dissolved and store at 4C. Inject 100 μl per mouse SQ or IP.

Solvent control should be prepared using 350 μl 80% ethanol instead of peptide solution

*Note: Purebright SL-220 is a phospholipid-PEG solubilizer made by NOF Corporation (Japan)), and is now called DSPE-020CN.
USA contact: https://www.nofamerica.com/store
European contact: https://www.nofeurope.com/drug-delivery-systems/